61/100B51.365
USD
-0.33
(-0.64%)
Market Closed
Last updated: · Delayed 15 min
Fair valueNot reliable
Q4 FY2026 · Earnings report
EPS estimate 0.23Revenue estimate 1.25B
Q4 FY2026 · Earnings report
EPS estimate 0.23Revenue estimate 1.25B
Genmab A shares outstanding 2002–2026What are shares outstanding? Shares outstanding are all the shares a company has issued that investors hold, insiders included. Their number times the share price is the market value.
Genmab A/S ADS had 616,593,650 shares outstanding on 14 November 2026. Genmab A/S ADS had 637.24M diluted shares on average over the last twelve months, up 1.1% on the twelve months before. In fiscal year 2025 the average was 626.92M.
Last updated 8 Nov 2026 · Next report 16 Feb 2027
Shares outstanding
Change on the year
| Fiscal year | Period ending | Shares outstanding | Change on the year | Basic shares |
|---|---|---|---|---|
| TTM | 30 Sept 2026 | 637.24M | +1.09% | 614.07M |
| FY2025 | 31 Dec 2025 | 626.92M | -3.00% | 621.51M |
| FY2024 | 31 Dec 2024 | 646.33M | -1.94% | 646.33M |
| FY2023 | 31 Dec 2023 | 659.15M | -0.14% | 659.15M |
| FY2022 | 31 Dec 2022 | 660.10M | -0.05% | 653.87M |
| FY2021 | 31 Dec 2021 | 660.46M | +0.24% | 653.96M |
| FY2020 | 31 Dec 2020 | 658.86M | +3.53% | 651.79M |
| FY2019 | 31 Dec 2019 | 636.37M | +2.57% | 629.63M |
| FY2018 | 31 Dec 2018 | 620.45M | -0.08% | 612.68M |
| FY2017 | 31 Dec 2017 | 620.94M | +0.53% | 608.34M |
| FY2016 | 31 Dec 2016 | 617.66M | +1.63% | 598.76M |
| FY2015 | 31 Dec 2015 | 607.74M | +6.15% | 585.21M |
| FY2014 | 31 Dec 2014 | 572.51M | +10.29% | 563.15M |
| FY2013 | 31 Dec 2013 | 519.10M | +12.74% | 509.77M |
| FY2012 | 31 Dec 2012 | 460.43M | +2.53% | 460.43M |
| FY2011 | 31 Dec 2011 | 449.07M | 0.00% | 449.07M |
| FY2010 | 31 Dec 2010 | 449.07M | +0.01% | 449.07M |
| FY2009 | 31 Dec 2009 | 449.04M | +0.59% | 449.04M |
| FY2008 | 31 Dec 2008 | 446.42M | +1.59% | 446.42M |
| FY2007 | 31 Dec 2007 | 439.45M | +12.89% | 439.45M |
| FY2006 | 31 Dec 2006 | 389.27M | +24.55% | 389.27M |
| FY2005 | 31 Dec 2005 | 312.55M | +18.08% | 312.55M |
| FY2004 | 31 Dec 2004 | 264.70M | +15.94% | 264.70M |
| FY2003 | 31 Dec 2003 | 228.31M | +2.22% | 228.31M |
| FY2002 | 31 Dec 2002 | 223.36M | — | 223.36M |
| Quarter | Period ending | Shares outstanding | Growth on a year before | Basic shares |
|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 620.69M | -0.01% | 612.90M |
| Q2 FY2026 | 30 Jun 2026 | 617.11M | -0.45% | 613.36M |
| Q1 FY2026 | 31 Mar 2026 | 638.55M | -0.12% | 613.84M |
| Q4 FY2025 | 31 Dec 2025 | 672.59M | +4.84% | 616.19M |
| Q3 FY2025 | 30 Sept 2025 | 620.74M | -4.33% | 615.98M |
| Q2 FY2025 | 30 Jun 2025 | 619.93M | -4.46% | 617.65M |
| Q1 FY2025 | 31 Mar 2025 | 639.34M | -2.63% | 637.25M |
| Q4 FY2024 | 31 Dec 2024 | 641.54M | -2.48% | 641.54M |
| Q3 FY2024 | 30 Sept 2024 | 648.85M | -1.50% | 648.85M |
| Q2 FY2024 | 30 Jun 2024 | 648.85M | -1.45% | 648.85M |
| Q1 FY2024 | 31 Mar 2024 | 656.59M | -0.26% | 653.03M |
| Q4 FY2023 | 31 Dec 2023 | 657.87M | -0.43% | 653.06M |
| Q3 FY2023 | 30 Sept 2023 | 658.73M | -0.07% | 653.07M |
| Q2 FY2023 | 30 Jun 2023 | 658.42M | -0.21% | 652.40M |
| Q1 FY2023 | 31 Mar 2023 | 658.31M | -0.19% | 654.21M |
| Q4 FY2022 | 31 Dec 2022 | 660.70M | -0.11% | 652.85M |
| Q3 FY2022 | 30 Sept 2022 | 659.18M | -0.23% | 652.84M |
| Q2 FY2022 | 30 Jun 2022 | 659.80M | +0.05% | 655.01M |
| Q1 FY2022 | 31 Mar 2022 | 659.57M | -0.04% | 657.34M |
| Q4 FY2021 | 31 Dec 2021 | 661.42M | +0.09% | 654.06M |
| Q3 FY2021 | 30 Sept 2021 | 660.73M | +0.23% | 653.93M |
| Q2 FY2021 | 30 Jun 2021 | 659.48M | +0.25% | 653.85M |
| Q1 FY2021 | 31 Mar 2021 | 659.84M | +0.33% | 653.94M |
| Q4 FY2020 | 31 Dec 2020 | 660.81M | +0.44% | 660.81M |
| Q3 FY2020 | 30 Sept 2020 | 659.20M | +1.64% | 651.91M |
| Q2 FY2020 | 30 Jun 2020 | 657.84M | +4.48% | 651.12M |
| Q1 FY2020 | 31 Mar 2020 | 657.70M | +6.88% | 651.33M |
| Q4 FY2019 | 31 Dec 2019 | 657.89M | +5.95% | 649.57M |
| Q3 FY2019 | 30 Sept 2019 | 648.55M | +4.61% | 640.81M |
| Q2 FY2019 | 30 Jun 2019 | 629.63M | +1.75% | 615.94M |
| Q1 FY2019 | 31 Mar 2019 | 615.38M | -0.83% | 610.17M |
| Q4 FY2018 | 31 Dec 2018 | 620.94M | -0.22% | 614.82M |
| Q3 FY2018 | 30 Sept 2018 | 619.98M | -1.78% | 619.98M |
| Q2 FY2018 | 30 Jun 2018 | 618.83M | -0.31% | 611.57M |
| Q1 FY2018 | 31 Mar 2018 | 620.54M | +0.22% | 611.00M |
| Q4 FY2017 | 31 Dec 2017 | 622.34M | +0.56% | 611.10M |
| Q3 FY2017 | 30 Sept 2017 | 631.22M | +2.22% | 631.22M |
| Q2 FY2017 | 30 Jun 2017 | 620.74M | +0.36% | 608.45M |
| Q1 FY2017 | 31 Mar 2017 | 619.19M | +2.08% | 596.26M |
| Q4 FY2016 | 31 Dec 2016 | 618.88M | +4.12% | 600.95M |
| Q3 FY2016 | 30 Sept 2016 | 617.51M | +1.25% | 599.86M |
| Q2 FY2016 | 30 Jun 2016 | 618.49M | +1.28% | 596.56M |
| Q1 FY2016 | 31 Mar 2016 | 606.58M | +1.61% | 606.58M |
| Q4 FY2015 | 31 Dec 2015 | 594.40M | +2.85% | 573.69M |
| Q3 FY2015 | 30 Sept 2015 | 609.86M | +6.01% | 589.36M |
| Q2 FY2015 | 30 Jun 2015 | 610.70M | +7.43% | 588.89M |
| Q1 FY2015 | 31 Mar 2015 | 596.95M | +6.66% | 571.82M |
| Q4 FY2014 | 31 Dec 2014 | 577.95M | +8.54% | 577.95M |
| Q3 FY2014 | 30 Sept 2014 | 575.26M | +7.67% | 575.26M |
| Q2 FY2014 | 30 Jun 2014 | 568.48M | +12.17% | 568.48M |
| Q1 FY2014 | 31 Mar 2014 | 559.66M | +10.40% | 550.28M |
| Q4 FY2013 | 31 Dec 2013 | 532.46M | +11.49% | 510.13M |
| Q3 FY2013 | 30 Sept 2013 | 534.30M | +14.97% | 534.30M |
| Q2 FY2013 | 30 Jun 2013 | 506.82M | +12.86% | 506.82M |
| Q1 FY2013 | 31 Mar 2013 | 506.94M | +16.75% | 503.42M |
| Q4 FY2012 | 31 Dec 2012 | 477.58M | +6.47% | 477.58M |
| Q3 FY2012 | 30 Sept 2012 | 464.75M | +3.44% | 464.75M |
| Q2 FY2012 | 30 Jun 2012 | 449.07M | -0.23% | 449.07M |
| Q1 FY2012 | 31 Mar 2012 | 434.22M | -3.31% | 434.22M |
| Q4 FY2011 | 31 Dec 2011 | 448.57M | -0.12% | 448.57M |
| Q3 FY2011 | 30 Sept 2011 | 449.28M | -0.14% | 449.28M |
| Q2 FY2011 | 30 Jun 2011 | 450.11M | +0.23% | 450.11M |
| Q1 FY2011 | 31 Mar 2011 | 449.07M | 0.00% | 449.07M |
| Q4 FY2010 | 31 Dec 2010 | 449.12M | -0.04% | 449.12M |
| Q3 FY2010 | 30 Sept 2010 | 449.93M | -0.01% | 449.93M |
| Q2 FY2010 | 30 Jun 2010 | 449.07M | 0.00% | 449.07M |
| Q1 FY2010 | 31 Mar 2010 | 449.07M | +0.00% | 449.07M |
| Q4 FY2009 | 31 Dec 2009 | 449.31M | — | 449.31M |
| Q3 FY2009 | 30 Sept 2009 | 449.98M | — | 449.98M |
| Q2 FY2009 | 30 Jun 2009 | 449.07M | — | 449.07M |
| Q1 FY2009 | 31 Mar 2009 | 449.06M | — | 449.06M |
Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.
See also:Revenue,Net income,EPS,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement
Common questions about Genmab A's shares
Source: Financial Modeling Prep